{
    "SPADE_N_00059": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 2023/0416797 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2023-12-28",
                "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1",
                "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE",
                "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."
            },
            {
                "Patent No": "US 2023/0416797 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2023-12-28",
                "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1",
                "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE",
                "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_00059",
            "Peptide Name": "Bacteriocin curvaticin",
            "Source": "Lactobacillus curvatus L442 (Gram-positive bacteria)",
            "Family": "Belongs to the class IIa bacteriocin",
            "Gene": "Not found",
            "Sequence": "AYPGNGVHCGKYSCTVDKQTAIGNIGNNAA",
            "Sequence Length": 30,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P84886"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+"
            ],
            "Target Organism": "Gram-positive bacteria:Listeria monocytogenes, Lactobacillus sakeii, Lactobacillus plantarum, Lactobacillus farciminis.",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "Not included yet",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not included yet",
            "N-terminal Modification": "Not included yet",
            "C-terminal Modification": "Not included yet",
            "Stereochemistry": "Not included yet",
            "Structure Description": "Not found",
            "Formula": "C127H199N39O43S2",
            "Mass": 3024.3,
            "PI": 8.07,
            "Net Charge": 2,
            "Hydrophobicity": -0.36,
            "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Has antibacterial activity.",
            "PTM": "Problely contains one disulfide bond 9-14.",
            "Biophysicochemical properties": "pH dependence (Stable below pH 6) and Temperature dependence (Stable below 60 degrees Celsius. Activity decreases sharply at temperatures above 60 degrees Celsius).",
            "Literature": [
                {
                    "Title": "Purification and characterization of curvaticin L442, a bacteriocin produced by Lactobacillus curvatus L442.",
                    "Pubmed ID": "16244793",
                    "Reference": "Antonie Van Leeuwenhoek. 2006 Jan;89(1)19-26.",
                    "Author": "Xiraphi N, Georgalaki M, Driessche GV, Devreese B, Beeumen JV, Tsakalidou E, Metaxopoulos J, Drosinos EH.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16244793"
                }
            ],
            "Frequent Amino Acids": "GAN",
            "Absent Amino Acids": "EFLMORUW",
            "Basic Residues": 3,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 11,
            "Polar Residues": 21,
            "Positive Residues": 3,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00085",
                    "Similarity": 0.8333333333333334,
                    "Sequence": "KYYGNGVHCGKHSCTVDWGTAIGNIGNNAAANWATGGNAGWNK"
                },
                {
                    "SPADE_ID": "SPADE_N_06139",
                    "Similarity": 0.8333333333333334,
                    "Sequence": "MEKFIELSLKEVTAITGGKYYGNGVHCGKHSCTVDWGTAIGNIGNNAAANWATGGNAGWNK"
                },
                {
                    "SPADE_ID": "SPADE_N_08714",
                    "Similarity": 0.8333333333333334,
                    "Sequence": "KYYGNGVHCGKHSCTVDWGTAIGNIGNNAAANWATGGNAGWNKS"
                }
            ]
        }
    }
}